Results 11 to 20 of about 17,628 (210)
Can primary optimal cytoreduction be predicted in advanced epithelial ovarian cancer preoperatively? [PDF]
Introduction Prediction of optimal cytoreduction in patients with advanced epithelial ovarian caner preoperatively. Methods Patients with advanced epithelial ovarian cancer who underwent surgery for the first time from Jan.
Behtash Nadereh +5 more
doaj +2 more sources
Background: Pre-cytoreduction refers to the administration of initial chemotherapy to reduce tumor burden prior to initiating definitive multi-agent chemotherapy.
Reena Kumari Sunil +3 more
doaj +2 more sources
Impact of tumor cytoreduction in metastatic prostate cancer
Yaya Sow, Ousmane Sow, Boubacar Fall, Babacar Sine, Alioune Sarr, Cyrille Zé Ondo, Babacar Diao, Alain Khassim Ndoye, Mamadou BaUrology and Andrology Department at Aristide Le Dantec Hospital, Cheikh Anta Diop University, Dakar, SenegalObjective ...
Sow Y +8 more
doaj +1 more source
Background: Tumor morcellation happened to facilitate iatrogenic metastasis for patients with occult uterine sarcoma. The optimal completion surgery for these patients needed to be established.
Chao Ding, Jianqing Zhu
doaj +2 more sources
Feasibility and Safety of Venetoclax for Cytoreduction During Induction Therapy in Newly Diagnosed Acute Promyelocytic Leukemia. [PDF]
ABSTRACT Objective This study aimed to evaluate the feasibility and safety of venetoclax as a cytoreductive strategy during induction therapy in newly diagnosed acute promyelocytic leukemia (APL), and to provide an exploratory description of its early efficacy.
Wang Y, Xiao R, Huang X, Xiao Y.
europepmc +2 more sources
Cytoreductive surgery (CRS) is the cornerstone of treating advanced ovarian cancer. Approximately 60–70% of patients with advanced ovarian cancer will have involvement in the upper abdomen or the supracolic compartment of the abdominal cavity ...
Olivier Glehen +3 more
core +1 more source
Background The role of pre‐hematopoietic stem cell transplantation (HSCT) cytoreduction with either induction chemotherapy (IC) or hypomethylating agents (HMAs) in treating advanced myelodysplastic syndrome (MDS) remains debatable.
Yu‐Qian Sun +7 more
doaj +1 more source
A Cohort Study to Decode the Application of Peritoneal Carcinomatosis Index in Predicting the Prognosis of Advanced Ovarian Malignancies [PDF]
Introduction: Peritoneal Carcinomatosis Index (PCI) is used to assess the extent of peritoneal cancer by dividing the peritoneal cavity into 13 well-defined regions and assessing the size of the largest tumour nodule in each region. Aim: To evaluate the
Athul Damodaran +2 more
doaj +1 more source
The application of pringle manoeuvre, type three liver mobilisation, full thickness diaphragmatic resection with primary closure technique and peritonectomy in the management of advanced ovarian malignancy [PDF]
Objective We present an educational technique for the safe completion of complete cytoreduction of diaphragmatic disease for the management of advanced ovarian malignancy.
Sarah Louise Smyth +1 more
doaj +1 more source
The impact of time and team on primary cytoreduction outcomes [PDF]
The degree of cytoreduction at time of initial surgery for epithelial ovarian cancers is correlated with overall survival. Given that surgery can be physically and mentally taxing on the surgeon, we sought to examine if there were temporal and/or team ...
Heather Williams +15 more
core +1 more source

